Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.

ABSTRACT:

Objectives

This analysis examined the association between psoriasis severity, assessed by body surface area (BSA) and the Investigator's Global Assessment (IGA; previously used only in clinical trials), and patient-reported outcomes (PROs) in a real-world setting.

Design

Cross-sectional analysis within the Corrona Psoriasis Registry, an independent, prospective registry.

Setting

70 dermatology practices in the USA.

Participants

1529 adult patients with psoriasis being treated with biological or non-biological systemic psoriasis treatment by 31 May 2016.

Primary and secondary outcome measures

Psoriasis severity was assessed by percentage of affected BSA (mild (0%-5%), moderate (>5%-10%), severe (>10%-15%), very severe (>15%)) and IGA scores (clear/almost

SUBMITTER: Strober B 

PROVIDER: S-EPMC6500315 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature